ArticleBMJ open2021

Comparative efficacy and safety of anti-HGF/MET pathway agents plus chemotherapy versus chemotherapy alone as first-line treatment in advanced gastric cancer: a protocol for a systematic review and meta-analysis.

Zhiyuan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.